Chitosan in an inhalable nanovaccine against SARS-CoV-2
The global corona pandemic requires effective vaccines to achieve herd immunity. In the study presented here, an inhalable chitosan-based nanovaccine containing the viral spike protein (S) was developed to specifically induce immunity at the mucosal sites of the respiratory tract.
chitosan, nanoparticles, vaccine
Read more Chitosan in an inhalable nanovaccine against SARS-CoV-2